© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Aspirin lysinate is a salt form of acetylsalicylic acid, created by combining aspirin with lysine, an essential amino acid. This product holds a unique place as it brings together the well-recognized effectiveness of aspirin with the improved solubility and gentler profile contributed by lysine. Unlike standard aspirin tablets or powders, aspirin lysinate offers greater solubility in water, which proves useful in both pharmaceutical and raw chemical applications. Aspirin, widely known for its analgesic, antipyretic, and anti-inflammatory properties, often causes gastrointestinal irritation—a common downside in daily healthcare and in industrial-scale processing. The lysinate form can mitigate some of these problems, offering a raw material that allows for easier handling and potentially improved safety in both lab and manufacturing settings.
This compound carries the chemical formula C9H7O2COOC6H14N2O2. Two familiar components stand out—acetylsalicylic acid and lysine—with a molecular weight around 327.36 g/mol. Structurally, it combines the carboxylic properties of aspirin with lysine’s amino acid backbone, producing a zwitterionic salt with increased water solubility. This structure affects both how the raw material reacts in solution and how it integrates with other compounds during formulation, key details for chemists looking for predictability in their ingredients.
In practice, aspirin lysinate most often appears as a white or near-white powder, but under varying conditions it may also be produced as small, crystalline flakes. Density comes in at about 1.3 g/cm³, although the actual bulk density during storage or transfer changes based on the precise form—crystalline, powder, or flakes. Unlike pure aspirin, the lysinate version readily dissolves in water, producing clear, buffered solutions with a neutral to slightly alkaline pH. From personal time spent handling both aspirin and its lysinate salt, this shift in solubility changes clean-up and processing, cutting down on residues and making scaling batches for formulation easier to manage in small labs and larger plants alike. Although a solid at room temperature, heating dissolves it smoothly in aqueous solutions, yet exposure to strong acids reverts some portion to less soluble acetylsalicylic acid. This interplay of basic and acidic properties matters for anyone setting up quality control in the supply chain.
Industry and pharmaceutical buyers look for purity levels above 98%, with common assays running chromatographic or titrimetric methods to verify the absence of free salicylic acid, degradation byproducts, or residual solvents. Product batches typically come packaged in sealed, inert gas-flushed bags or drums to guard against hydrolysis and absorption of stray moisture—two common headaches for warehouses storing raw chemicals over months at a time. Particle size distribution depends on the intended use; fine powder supports faster dissolution and mixing in liquid formulations, while larger granules work better for extended-release prototypes. Packaging sizes range from small kilo-scale bags for product development up to multi-tonne drums for high-throughput manufacturers. In all cases, the “HS Code” for import/export aligns with the broader heading for acetylsalicylic acid and its derivatives, which for many customs regimes sits around 291821.
Despite the improvements in gastrointestinal tolerability, this chemical retains some of the hazards familiar from regular aspirin. It can cause mild skin or eye irritation, and fine powder in large quantities presents the risk of airborne particle inhalation—worth noting in the context of poorly ventilated storage or transfer areas. Standard chemical training recommends gloves, goggles, and particulate masks when pouring or weighing amounts over several grams. Aspirin lysinate itself falls under “harmful” rather than “highly toxic” classifications for occupational limits, but chronic exposure or poor containment can lead to headaches, respiratory irritation, or rare hypersensitivity responses. Spills can be dampened and swept, with residue handled as non-hazardous waste unless the product is contaminated with other industrial byproducts. In the laboratory, heating or mixing with strong acids deserves attention; hydrolysis can release acetic acid fumes and revert the substance to regular aspirin, sometimes causing clumping or changes in solubility. All these quirks boil down to real-world requirements, driving companies to double-check their MSDS updates and advise staff in handling drums or processing lines—because paperwork is only as good as the person pouring the powder.
Aspirin lysinate steps in as a favored raw material where both rapid solubility and established aspirin action are needed. It has shown consistent uptake in the manufacture of injectable aspirin for use in hospital emergency and post-operative care, as quick dissolution into sterile solutions saves time, reduces the risk of particulate formation, and eases the burden on pharmacy staff. In solid oral delivery, manufacturers choose it for buffered or combination tablets to control stomach irritation in patients who already struggle with regular aspirin. The presence of lysine can sometimes support recovery and metabolic function, making the compound a preferred choice in sports medicine and rehabilitation formulations. Smaller-scale supplement companies also look to this material; it grants a way to deliver the analgesic benefits of aspirin with the suggestion of improved tolerability.
Consistent quality across lots proves essential in almost every chemical supply chain, and aspirin lysinate is no exception. The two critical raw materials—acetylsalicylic acid and high-purity lysine—must be free of contaminants, as trace organic solvents or unreacted precursors undermine both safety and reliability. Over the years, I’ve watched supply bottlenecks ripple through both components when upstream fermentation yields for lysine falter, underscoring the interconnected nature of pharmaceutical chemistry. Reliable vendors back up their shipments with full traceability, batch-specific certificates of analysis, and ongoing audits; these practices match the rising expectations from regulators and end users alike, especially after recent recalls over substandard excipients in other drug classes. Sourcing managers learn quickly that shortcuts here lead to rejected batches, lost production days, or—worst of all—product withdrawals. With competition for top-grade raw chemicals growing every year, staying informed on vendor practices and establishing solid backup contracts makes the difference between a successful launch and an expensive delay.
Though less caustic than some pharmaceutical precursors, aspirin lysinate still presents risk if mishandled. In large-scale settings, accidental spills run down drains and reach waterways, so treatment and containment systems need to be kept in order to protect aquatic life and avoid regulatory fines. On the patient side, lysinate versions allow for reduced stomach upset, but overuse of all aspirin forms still carries bleeding and allergy risks that responsible formulators and pharmacists must spell out. With so many cases of drug-induced gastric ulcers, any improvement provided by the salt form contributes to better patient experiences and fewer hospital visits. Staff education, clear labeling, and ongoing monitoring for adverse effects remain central to responsible use, reinforcing the point that no chemical—no matter how well understood—exists in a vacuum. Safe disposal, smart manufacturing, and clinical vigilance come together to ensure that aspirin lysinate’s benefits far outweigh the challenges of handling it as either a raw material or finished pharmaceutical ingredient.
